Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Tomorrow we should see some substantial increase in pps.
Congrats to all of us NEOP holders. :)
NEOP $5.20 ah :)
I don't use stop losses because of that. If you do it should be bracketed.
It seems to be the norm before data comes out.
Agreed.
Bear raid.
It sure is and a good buying opp:)
AEZS reminds me of LEXG when it started a huge run.
OPTR-$12.71....Optimer Pharmaceuticals to Present at May 2011 Investor ConferencesOptimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Company will present at the following investor conferences:
JMP Securities Tenth Annual Research Conference on Tuesday, May 10, 2011 at 2:30 p.m. Pacific Time at the Ritz-Carlton in San Francisco.
Bank of America Merrill Lynch 2011 Health Care Conference on Thursday, May 12, 2011 at 9:50 a.m. Pacific Time at Encore at Wynn Las Vegas.
UBS Global Specialty Pharmaceuticals Conference on Tuesday, May 24, 2011 at 12:00 p.m. British Summer Time at the UBS offices in London.
http://ih.advfn.com/p.php?pid=nmona&article=47469703&symbol=OPTR
SPPI getting hammered!
ONTY-$4.10, down .84-Oncothyreon Prices $40.0 Million Public Offering of Common StockSEATTLE, April 29 /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ:ONTY - News) today announced that it has priced an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $4.00 per share for gross proceeds of $40.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Oncothyreon, will be approximately $37.4 million. Oncothyreon has also granted the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any, which would result in additional gross proceeds of approximately $6.0 million if exercised in full.
http://finance.yahoo.com/news/Oncothyreon-Prices-400-prnews-1516490484.html?x=0&.v=26
KERX-$5.40....Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex Short-Term Phase 3 StudyData Presented During Oral Presentation at Ongoing National Kidney Foundation Spring Clinical Meeting NEW YORK, April 28, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals (Nasdaq:KERX - News) today announced the final dataset from the Phase 3 short-term clinical trial of Zerenex™ (ferric citrate) for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. The Zerenex data was presented earlier today at the National Kidney Foundation Spring Clinical Meetings being held in Las Vegas, Nevada, in an oral presentation by David S. Goldfarb, M.D., Clinical Chief of Nephrology, NYU Langone Medical Center, Professor of Medicine & Physiology, NYU School of Medicine. On November 30, 2010, the Company issued a press release announcing positive top-line results from this Phase 3 short-term study.
http://finance.yahoo.com/news/Keryx-Biopharmaceuticals-prnews-3932846248.html?x=0&.v=1
I agree with your no buyout but May is almost here and still waiting on Teva. They could run into more delays.
Agreed.
SPPI has also broken 8 year long term resistance of $10
I believe it has a 70% chance of approval. I'm long SPPI.
SPPI...$10.04 breaking an 8 year long term resistance of $10
You need to read the full filing. It is a mixed shelf. They can sell shares at anytime, not neccessarily right now.
brick, good article. thx
To the contrary? I'm already in at a lower price than what it is trading at now or I would buy more NOW.
Congrats, good move.
Right now it's a good buying opp.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: x
They are not neccessarily going to sell any shares immediately.
It can happen anytime and is nothing to be worried about. IMO
This is nothing more than a mixed shelf. They can sell shares anytime as needed according to market conditions. NEOP may not do it for a while, but it is definitely nothing to sell your shares over.
What's up with all the volume?
I hope so. I expect OPTR to move up as its May 30 PDUFA approaches.
10.4 mil dv 3/12/10
No pr on this?
congrats, wish I knew more about options.
NEOP....$5.00......
You're not having buyer's remorse , are you? :)
AEZS.....Share Statistics
Avg Vol (3 month)3: 2,610,690
Avg Vol (10 day)3: 7,093,870
Shares Outstanding5: 85.26M
Float: 84.79M
% Held by Insiders6: 7.11%
% Held by Institutions6: 9.20%
Shares Short (as of Mar 31, 2011)3: 6.11M
Short Ratio (as of Mar 31, 2011)3: 2.40
Short % of Float (as of Mar 31, 2011)3: N/A
Shares Short (prior month)3: 5.98M
http://finance.yahoo.com/q/ks?s=AEZS+Key+Statistics
It would be great to get Fusilev approval today on top of this pr.
TLON .865 breaking through .85 resistance.
No not hard date.
I wonder if Allergan will try to buy FCSC? LaViv is definitely going to hurt Botox sales.
I agree. LaViv, better choice than Botox.
SPPI. Anybody have any opinions on FDA approval for Fusilev on Friday?